Neutrogena T-Gel use with Merck's Propecia Rx baldness drug suggested by FDA cmte.

NEUTROGENA T-GEL/MERCK PROPECIA CONCOMITANT USE RECOMMENDED for the Rx baldness treatment by FDA's Dermatologic & Ophthalmic Drugs Advisory Committee during the group's Nov. 13 review of the oral hair regrowth drug finasteride. FDA had asked the committee to consider the effect of Neutrogena's OTC coal tar dandruff shampoo "on the assessment of the treatment response to Propecia." T-Gel was used in both the treatment and control groups of Merck's safety and efficacy trial for Propecia as a prophylaxis for seborrheic dermatitis, which, according to the company, is a condition often seen in balding men. The recommended dose of T-Gel during the trial was not specified.